Polycyclic Aromatic Hydrocarbons Activate the Aryl Hydrocarbon Receptor and the Constitutive Androstane Receptor to Regulate Xenobiotic Metabolism in Human Liver Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
31 Dec 2020
Historique:
received: 30 11 2020
revised: 18 12 2020
accepted: 26 12 2020
entrez: 5 1 2021
pubmed: 6 1 2021
medline: 7 4 2021
Statut: epublish

Résumé

Polycyclic aromatic hydrocarbons (PAHs) are environmental pollutants produced by incomplete combustion of organic matter. They induce their own metabolism by upregulating xenobiotic-metabolizing enzymes such as cytochrome P450 monooxygenase 1A1 (CYP1A1) by activating the aryl hydrocarbon receptor (AHR). However, previous studies showed that individual PAHs may also interact with the constitutive androstane receptor (CAR). Here, we studied ten PAHs, different in carcinogenicity classification, for their potential to activate AHR- and CAR-dependent luciferase reporter genes in human liver cells. The majority of investigated PAHs activated AHR, while non-carcinogenic PAHs tended to activate CAR. We further characterized gene expression, protein abundancies and activities of the AHR targets CYP1A1 and 1A2, and the CAR target CYP2B6 in human HepaRG hepatoma cells. Enzyme induction patterns strongly resembled the profiles obtained at the receptor level, with AHR-activating PAHs inducing CYP1A1/1A2 and CAR-activating PAHs inducing CYP2B6. In summary, this study provides evidence that beside well-known activation of AHR, some PAHs also activate CAR, followed by subsequent expression of respective target genes. Furthermore, we found that an increased PAH ring number is associated with AHR activation as well as the induction of DNA double-strand breaks, whereas smaller PAHs activated CAR but showed no DNA-damaging potential.

Identifiants

pubmed: 33396476
pii: ijms22010372
doi: 10.3390/ijms22010372
pmc: PMC7796163
pii:
doi:

Substances chimiques

AHR protein, human 0
Basic Helix-Loop-Helix Transcription Factors 0
Constitutive Androstane Receptor 0
Polycyclic Aromatic Hydrocarbons 0
Receptors, Aryl Hydrocarbon 0
Receptors, Cytoplasmic and Nuclear 0
Xenobiotics 0
Cytochrome P-450 Enzyme System 9035-51-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : German Federal Institute for Risk Assessment
ID : 1322-544 and 51-006
Organisme : Deutsche Forschungsgemeinschaft
ID : LA1177/4-4 and SE552/4-3
Organisme : Robert Bosch Stiftung, Stuttgart, Germany
ID : x

Références

Mol Pharmacol. 2007 Jun;71(6):1475-86
pubmed: 17327465
Biochim Open. 2018 Jun 11;7:1-9
pubmed: 30003042
Mutat Res. 2001 Oct 18;497(1-2):49-62
pubmed: 11525907
IARC Monogr Eval Carcinog Risks Hum. 2010;92:1-853
pubmed: 21141735
Anal Biochem. 2006 Sep 1;356(1):94-9
pubmed: 16750160
Toxicol Appl Pharmacol. 2005 Aug 1;206(1):73-93
pubmed: 15963346
Arch Environ Contam Toxicol. 2002 May;42(4):477-85
pubmed: 11994790
Drug Metab Dispos. 2006 Jan;34(1):75-83
pubmed: 16204462
Mol Pharmacol. 2004 May;65(5):1225-37
pubmed: 15102951
Environ Res. 2004 Mar;94(3):262-6
pubmed: 15016593
Drug Metab Dispos. 2008 Jan;36(1):137-45
pubmed: 17954527
Mol Cell Biol. 1999 Sep;19(9):6318-22
pubmed: 10454578
Expert Opin Drug Metab Toxicol. 2012 Jul;8(7):803-17
pubmed: 22554043
Mutagenesis. 2016 Jan;31(1):43-50
pubmed: 26282955
Toxicol Sci. 2018 May 1;163(1):170-181
pubmed: 29420809
Science. 1996 Oct 18;274(5286):430-2
pubmed: 8832894
Chem Biol Interact. 2002 Sep 20;141(1-2):117-30
pubmed: 12213388
Environ Pollut. 2020 Nov;266(Pt 2):115125
pubmed: 32679438
J Biol Chem. 2004 Jun 4;279(23):23847-50
pubmed: 15028720
J Cell Biochem. 2005 Dec 15;96(6):1174-84
pubmed: 16211578
Chem Res Toxicol. 2005 Jun;18(6):976-83
pubmed: 15962932
Exp Lung Res. 1998 Jul-Aug;24(4):395-405
pubmed: 9659573
Pharmacogenomics J. 2002;2(2):117-26
pubmed: 12049174
Hum Mutat. 2010 Jan;31(1):27-40
pubmed: 19802894
Mol Pharmacol. 2010 Jul;78(1):46-57
pubmed: 20371670
Mol Pharmacol. 2002 Sep;62(3):737-46
pubmed: 12181452
Toxicol Lett. 2013 Oct 24;222(2):180-8
pubmed: 23845848
Anal Biochem. 2015 Oct 15;487:45-8
pubmed: 26212314
Drug Metab Pharmacokinet. 2006 Aug;21(4):257-76
pubmed: 16946553
Drug Metabol Drug Interact. 2013;28(2):79-93
pubmed: 23729557
FEBS Lett. 2009 Dec 17;583(24):3966-73
pubmed: 19850042
Mutat Res. 1996 Oct 28;358(1):97-112
pubmed: 8921980
Mol Pharmacol. 2013 Sep;84(3):304-13
pubmed: 23761301
Nat Rev Genet. 2012 Mar 13;13(4):227-32
pubmed: 22411467
Bioinformatics. 2016 Sep 15;32(18):2847-9
pubmed: 27207943
Arch Toxicol. 2020 Dec;94(12):4023-4035
pubmed: 32914219
Food Chem Toxicol. 2021 Jan;147:111884
pubmed: 33249052
Mol Biosyst. 2009 Dec;5(12):1512-26
pubmed: 20023718
Environ Mol Mutagen. 2005 Mar-Apr;45(2-3):106-14
pubmed: 15688365
Toxicol Appl Pharmacol. 2016 Jan 1;290:31-42
pubmed: 26603514
Environ Health Perspect. 2002 Jun;110 Suppl 3:451-88
pubmed: 12060843
Toxicol Appl Pharmacol. 2019 Sep 1;378:114618
pubmed: 31181217
EXCLI J. 2020 Jan 17;19:135-153
pubmed: 32194361
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cancer Res. 1985 Jul;45(7):3106-12
pubmed: 3839166
Int J Cancer. 2013 Sep 15;133(6):1300-9
pubmed: 23483552
Protein Cell. 2014 Feb;5(2):113-23
pubmed: 24474196
Mol Pharmacol. 2002 Aug;62(2):359-65
pubmed: 12130689
Toxicol Sci. 2014 Aug 1;140(2):259-70
pubmed: 24863967
Drug Metab Dispos. 2010 Sep;38(9):1589-97
pubmed: 20551241
Carcinogenesis. 1991 Oct;12(10):1939-44
pubmed: 1934274
Science. 1978 Feb 17;199(4330):778-81
pubmed: 622566
Immunity. 2018 Jan 16;48(1):19-33
pubmed: 29343438
Toxicol Sci. 2015 Oct;147(2):436-45
pubmed: 26160115
Biochem Cell Biol. 2003 Jun;81(3):123-9
pubmed: 12897845
Redox Biol. 2020 Jul;34:101530
pubmed: 32354640

Auteurs

Lisa Goedtke (L)

Department Food Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.

Heike Sprenger (H)

Department Food Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.

Ute Hofmann (U)

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstr. 112, 70376 Stuttgart, and University of Tübingen, 72074 Tübingen, Germany.

Felix F Schmidt (FF)

SIGNATOPE GmbH, Markwiesenstraße 55, 72770 Reutlingen, Germany.

Helen S Hammer (HS)

SIGNATOPE GmbH, Markwiesenstraße 55, 72770 Reutlingen, Germany.

Ulrich M Zanger (UM)

Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Auerbachstr. 112, 70376 Stuttgart, and University of Tübingen, 72074 Tübingen, Germany.

Oliver Poetz (O)

SIGNATOPE GmbH, Markwiesenstraße 55, 72770 Reutlingen, Germany.

Albrecht Seidel (A)

Biochemical Institute for Environmental Carcinogens, Prof. Dr. Gernot Grimmer Foundation, Lurup 4, 22927 Grosshansdorf, Germany.

Albert Braeuning (A)

Department Food Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.

Stefanie Hessel-Pras (S)

Department Food Safety, German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Straße 8-10, 10589 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH